New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...

Yonalink and PSP today announced a strategic collaboration aimed at simplifying the integration of medical information stored in Electronic Health Records (EHRs) into Electronic Data Capture (EDC) ...

The way we discover and test new medicines is undergoing a massive transformation for decades the process of bringing a life saving drug to the public was a slow, paper heavy journey that required ...

The PitchForce Investment Summit brings together innovative startups and active investors across the life sciences for a ...

World-leading challenge study expertise helping deliver scalable, high-quality outpatient vaccine trials in healthy ...

Effective Sjögren’s management demands a strict separation between symptomatic relief for sicca and immunosuppression for ...

ARCALYST® (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth –– ...

Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...

The Global Forced Air Warming Market Size projected to grow at a CAGR of 6.81% from 2025 to 2032, according to a new report ...

Independent survey of finance, revenue cycle, and clinical operations leaders recognizes XiFin's leadership as AI becomes essential to denial prevention, payor policy navigation, and financial ...

OpenAI's healthcare AI tools aim to improve care delivery, reduce administrative tasks, and ensure HIPAA compliance, ...

Top-quality care that is readily available and accessible is an important element of effective, high-performing communities ...